MetLife Investment Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

MetLife Investment Management’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-121,416	Closed	-$206K	–	2630
2018 Q3	$206K	Buy	121,416 +1,570	+1%	+$2.81K	﹤0.01%	2061
2018 Q2	$209K	Hold	119,846	–	–	﹤0.01%	1902
2018 Q1	$219K	Buy	119,846 +64,412	+116%	+$136K	﹤0.01%	1838
2017 Q4	$124K	Buy	+55,434	New	+$138K	﹤0.01%	2163

Other funds holding SGYP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

OCM

Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

MetLife Investment Management's SGYP Position: Q4 2018 in Review

MetLife Investment Management sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2018, closing a stake of 121,416 shares — an estimated $206K sold.

MetLife Investment Management first reported a position in SGYP in Q4 2017 and held it in 4 quarters. The position peaked at $219K in Q1 2018. 89 funds tracked by Wall St. Rank hold SGYP as of Q4 2018.

MetLife Investment Management reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2018 after selling out during the quarter.
MetLife Investment Management sold 121,416 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2018, an estimated $206K.
MetLife Investment Management first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2017 and held it in 4 quarters.
MetLife Investment Management's Synergy Pharmaceuticals, Inc Common Stock position peaked at $219K in Q1 2018.
89 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2018.

Based on MetLife Investment Management's 13F filing for Q4 2018, filed 14 Feb 2019.